Boric acid inhibits embryonic histone deacetylases: A suggested mechanism to explain boric acid-related teratogenicity
Authors:
- Graziella CappellettiGCGraziella Cappelletti
- Elena MenegolaEMElena Menegola
- 1 April 2007
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 220 (2) , 178-185
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicityBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2005
- Effects of hyperthermia and boric acid on skeletal development in rat embryosBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2005
- Boric acid inhibits human prostate cancer cell proliferationCancer Letters, 2004
- Defects in cervical vertebrae in boric acid‐exposed rat embryos are associated with anterior shifts of hox gene expression domainsBirth Defects Research Part A: Clinical and Molecular Teratology, 2003
- Histone-deacetylase inhibitors: novel drugs for the treatment of cancerNature Reviews Drug Discovery, 2002
- Transcriptional regulation in acute promyelocytic leukemiaOncogene, 2001
- Valproic Acid‐Induced Neural Tube Defects in Mouse and Human: Aspects of Chirality, Alternative Drug Development, Pharmacokinetics and Possible MechanismsBasic & Clinical Pharmacology & Toxicology, 1991
- Teratogenicity and developmental toxicity of valproic acid in ratsTeratology, 1987
- Borate inhibition of yeast alcohol dehydrogenaseBiochemistry, 1976
- Boron in Plants: A Biochemical RoleScience, 1967